Home > Financial Ratios > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 4.858.759.5238.6721.19

What is the latest EV/Core EBITDA ratio of NATCO PHARMA ?

The latest EV/Core EBITDA ratio of NATCO PHARMA is 4.85 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20254.85
Mar20248.75
Mar20239.52
Mar202238.67
Mar202121.19

How is EV/Core EBITDA of NATCO PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 4.85
-44.57
Mar2024 8.75
-8.09
Mar2023 9.52
-75.38
Mar2022 38.67
82.49
Mar2021 21.19 -

Other Financial Ratios of NATCO PHARMA


Compare EV/Core EBITDA ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹19,181.6 Cr -1.5% 11.9% 27.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,052.0 Cr -1.4% -6.2% -1.6% Stock Analytics
DIVIS LABORATORIES ₹169,336.0 Cr -0.1% 2.3% 9.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,311.0 Cr -1.8% -4.9% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,264.0 Cr -0.4% -6% 5.3% Stock Analytics
CIPLA ₹105,484.0 Cr 0.4% -2.6% -17.6% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.5%

11.9%

27.7%

SENSEX

-0.4%

1.3%

0.8%


You may also like the below Video Courses